The effect of vestibular stimulation on postural control in people with bilateral vestibulopathy
The effect of noisy galvanic vestibular stimulation on postural control in people with bilateral vestibulopathy
Auckland University of Technology
31 participants
Jun 14, 2024
Interventional
Conditions
Summary
Bilateral vestibulopathy (BVP) is a diagnosis where the neural signals that travel from the vestibular apparatus to the central nervous system are either absent or significantly reduced on both sides. This leads to imbalance, oscillopsia (visual blurring with head movement) and difficulty walking in darkness or over uneven surfaces. Vestibular hair cells and neurons do not regenerate, and there is currently no established remedial medical treatment for BVP once damage has occurred. An emerging treatment option is noisy galvanic vestibular stimulation (nGVS). A weak vestibular signal is boosted by a small nGVS signal, enhancing vestibular system performance, and improving balance. Most trials that have investigated the use of nGVS in people with BVP to date demonstrate positive, but varied, effects to improve postural instability in standing or walking. These studies are during a single session or two session trials. nGVS was a feasible adjunct to vestibular rehabilitation in further study, however, the efficacy of nGVS delivered as a rehab treatment is not yet established. This two-period randomised crossover trial will investigate whether people with bilateral vestibulopathy undertaking vestibular rehabilitation augmented with nGVS improve their postural stability more than vestibular rehabilitation with sham nGVS. We hypothesise that vestibular rehabilitation plus nGVS will result in improved postural control after four weeks of treatment compared to vestibular rehabilitation and sham stimulation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Vestibular rehabilitation plus noisy galvanic vestibular stimulation (nGVS) Vestibular rehabilitation will be for 45 minutes twice a week for 4 weeks and carried out in face to face treatments by a registered Physiotherapist. Vestibular rehabilitation will include exercises promoting: • Vestibular adaptation (strengthening residual vestibular afferent information) eg. Visual fixation on an object while moving head (x1 exercise), Visual fixation on moving object with head moving in opposite direction (x2 exercise) • Vestibular substitution (strengthening compensatory strategies) eg. Active eye and head movements between stationary targets, imaginary visual fixation with eyes closed, neck proprioception cueing • Balance and gait exercises eg. Multisensory balance training, training limits of stability, task specific training with modification of sensory inputs (vestibular, visual, somatosensory) • Reversing the effects of detraining/ sedentary lifestyle eg. Walking, stationary cycling, stationary rowing During 30 minutes of the vestibular rehabilitation participants will receive nGVS applied at parameters that have been shown to optimise the participant's postural control during an assessment prior to the clinical study. Machine: DC stimulator mobile electrodes: 5cm x 5cm carbon rubber electrode skin interface: saline soaked sponge Waveform: Gaussian white noise Frequency band: either 0.01- 10 or 0-30 depending on participant responsiveness Amplitude: the subthreshold amplitude that improves lateral gait variability the most. Adherence will be measured by participant attendance sheets In this crossover trial there is a 12 week washout period between treatment periods The order of treatment will be determined by random number generator. 50% of participants will receive the intervention treatment first, 50% of participants will receive the control treatment first.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12623000444684